SBRT with concurrent chemoradiation in stage III NSCLC: first results of the phase I Hybrid trial

被引：0
|
作者：
Peulen, H. [1 ]
Sonke, J. J. [1 ]
Van der Bijl, E. [1 ]
Damen, E. [1 ]
Belderbos, J. [1 ]
机构：
[1] Netherlands Canc Inst, Radiat Oncol, Amsterdam, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 119卷
关键词：
D O I：
10.1016/S0167-8140(16)31526-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PV-0277
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [31] Prognostic Role of NLR in Stage III NSCLC Undergoing Chemoradiation: Secondary Analysis of Proclaim Trial
    Biswas, T.
    Kang, K.
    Bajor, D.
    Dowlati, A.
    Machtay, M.
    Efird, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1125 - S1125
  • [32] A Phase I Trial to Evaluate Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Stage IV NSCLC
    Jelinek, M. J.
    Melotek, J. M.
    Vokes, E. E.
    Weichselbaum, R. R.
    Chmura, S. J.
    Patel, J. D.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1579 - S1580
  • [33] Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410
    Curran, Walter J., Jr.
    Paulus, Rebecca
    Langer, Corey J.
    Komaki, Ritsuko
    Lee, Jin S.
    Hauser, Stephen
    Movsas, Benjamin
    Wasserman, Todd
    Rosenthal, Seth A.
    Gore, Elizabeth
    Machtay, Mitchell
    Sause, William
    Cox, James D.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (19) : 1452 - 1460
  • [34] Concurrent chemoradiation versus radiotherapy alone in cervical carcinoma: A randomized phase III trial
    Srivastava, Kirti
    Paul, Sayan
    Chufal, Kundan Singh
    Shamsundar, Sunkappa Dayashankara
    Lal, Punita
    Pant, Mohan C.
    Bhatt, Madanlal
    Singh, Sudhir
    Gupta, Rajeev
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 (04) : 349 - 356
  • [35] A prospective study assessing the value of geriatric assessment in elderly patients with stage III NSCLC for concurrent chemoradiation.
    Rebollo, Maite Antonio
    Aceituno, Jennifer Linares
    Saldana, Juana
    Navarro, Arturo
    Arnaiz, Maria Dolores
    Ruffinelli, Jose Carlos
    Palmero, Ramon
    Plana, Maria
    Brao, Isabel
    Padrones, Susana
    Navarro-Perez, Valentin
    Cardenal, Felipe
    Nadal-Alforja, Ernest
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] ACTLACC TRIAL: A PHASE III RANDOMIZED TRIAL COMPARING ADJUVANT CHEMOTHERAPY AFTER CONCURRENT CHEMORADIATION VERSUS CONCURRENT CHEMORADIATION ALONE FOR LOCALLY ADVANCED CERVICAL CANCER
    Tangjitgamol, S.
    Tharavichitkul, E.
    Tovanabutra, C.
    Rongsriyam, K.
    Asakij, T.
    Paengchit, K.
    Sukhaboon, J.
    Penpattanagul, S.
    Kridakara, G. C. A.
    Hanprasertpong, J.
    Chomprasert, K.
    Wanglikitkoon, S.
    Atjimakul, T.
    Pariyawateekul, S. L. P.
    Katanyoo, K.
    Tanprasert, P.
    Janweerachai, W.
    Khunnarong, J.
    Srisomboon, J.
    Lorvidhaya, V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 6 - 7
  • [37] Cilengitide in continuous infusion with radio-chemotherapy in stage III NSCLC: A phase I clinical trial
    Moyal, E. Cohen-Jonathan
    Massabeau, C.
    Filleron, T.
    Modesto, A.
    Bachaud, J. M.
    Rouquette, I.
    Dierickx, L.
    Aziza, R.
    Bigay-Game, L.
    Plat, G.
    Mounier, M.
    Gomez-Roca, C.
    Delord, J. P.
    Mazieres, J.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S291 - S291
  • [38] ADRIATIC: A phase III trial of durvalumab ± tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer
    Schulz, C.
    Senan, S.
    Shire, N.
    Mak, G.
    Yao, W.
    Reinmuth, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 253 - 254
  • [39] A Phase II Trial of Concurrent Chemoradiation with Consolidation Pembrolizumab in Unresectable Stage III Non-Small Cell Lung Cancer
    Durm, Greg
    Hanna, Nasser
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S569 - S570
  • [40] Preoperative chemoradiation in addition to preoperative chemotherapy in stage III NSCLC
    Nature Clinical Practice Oncology, 2008, 5 (10): : 566 - 566
12345